Skip to content

Evaluation of the Usefulness of Texture and Color Enhancement Imaging (TXI) for Activity Assessment in Ulcerative Colitis

Evaluation of the Usefulness of Texture and Color Enhancement Imaging (TXI) for Activity Assessment in Ulcerative Colitis - Evaluation of the Usefulness of Texture and Color Enhancement Imaging (TXI) for Activity Assessment in Ulcerative Colitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042730
Enrollment
300
Registered
2020-12-11
Start date
2020-12-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Interventions

None listed

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have been previously diagnosed with ulcerative colitis Patients who will undergo lower gastrointestinal endoscopy due to clinical necessity

Exclusion criteria

Exclusion criteria: Patients undergoing lower gastrointestinal endoscopy without prior treatment Patients with or suspected of having intestinal obstruction, stenosis, fistula, post-operative colorectal surgery, infectious enteritis, or active colonic bleeding. Patients with a history of radiation therapy to the abdomen or pelvis Tissue biopsy is not possible (e.g., chronic blood disease or taking anticoagulant or antiplatelet drugs) Patients who do not consent to this study

Design outcomes

Primary

MeasureTime frame
Correlation between inflammation assessment and relapse using TXI in ulcerative colitis

Secondary

MeasureTime frame
Correlation between inflammation assessment by TXI and RDI, Mayo endoscopic score, and pathology score (Geboes index),Inter-observer agreement between inflammation assessment by TXI and RDI, Mayo endoscopic score, and pathology score (Geboes index).

Countries

Japan

Contacts

Public ContactYukie Hayashi

Keio University School of Medicine Division of Gastroenterology and Hepatology, Department of Internal Medicine

yukie_tennis_0929@yahoo.co.jp0333531211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026